When do HIV-infected persons start with antiretroviral therapy? A retrospective analysis of patients' monitoring and treatment status in general practice, as compared with the 1991 Dutch HIV treatment guidelines

Family Practice

Volumn 15, Issue 6, 1998, Pages 525-528

  Reedijk, Mirjam ^b   Wigersma, Lode ^a   Mohrs, Jacob ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

Antiretroviral therapy; General practice; HIV infection; The Netherlands; Treatment guidelines

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; ATTITUDE; DISEASE COURSE; FEMALE; GENERAL PRACTICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PATIENT MONITORING; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FAMILY PRACTICE; FEMALE; GUIDELINE ADHERENCE; HIV INFECTIONS; HUMANS; MALE; NETHERLANDS; PATIENT SELECTION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0032465325     PISSN: 02632136     EISSN: None     Source Type: Journal    
DOI: 10.1093/fampra/15.6.525     Document Type: Article

References (15)

1. Wigersma L. Buster MCA, Van Brussel GHA. Distribution of care for HIV infected patients over general practices in Amsterdam: similarity to the distribution of care for drug users (in Dutch). Huisarts Wet (submitted for publication).
2. van Everdingen JJE, Lange JMA. Consensus vroegtijdige interventie met zidovudine (Consensus early treatment with zidovudine). Ned Tijdschr Geneeskd 1991; 135: 1547-1550.
3. Hammer SM. Advances in antiretroviral therapy and viral load monitoring. AIDS 1996; 10 (suppl 3): S1-S11.
4. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1996. JAMA 1996; 276: 146-154.
5. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors; a review for clinicians. JAMA 1997; 277: 145-153.
6. Ancelle-Park R. Expanded European AIDS Case definition. Lancet 1993; 341: 441.
7. Volberding PA. Treatment dilemmas in HIV infection. Hosp Pract (Off Ed) 1994; 29: 49-60.
8. Aboulker JP. Preliminary analysis of the Concorde trial (letter). Lancet 1993; 341: 889-890.
9. Mcnulty AM, Kaldor JM, Cooper DA. Change in zidovudine prescribing practices in Australia, 1991-1993. Aust NZ J Med 1995; 25: 239-240.
10. Schroeder K. Patient's attitude to Zidovudine: the influence of the Concorde trial and the media. AIDS 1994; 8: 1354-1355.
11. Nannis ED, Temoshok LR, Smith M, Jenkins RA. Perceptions of AZT: implications for adherence to medical regimens. J Appl Biobehav Res 1993; 1: 39-54.
12. Catt S, Stygall J, Catalan J. Acceptance of zidovudine in early HIV disease: the role of health beliefs. AIDS Care 1995; 7: 229-235.
13. Muma RD, Ross MW, Parcel GS, Pollard RB. Zidovudine adherence among individuals with HIV infection. AIDS Care 1995; 7: 439-447.
14. Siegel K, Raveis VH, Krauss BJ. Factors associated with urban gay men's treatment initiation decisions for HIV infection. AIDS Educ Prev 1992; 4: 135-142.
15. Stall R, Hoff C, Coates TJ, et al. Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr 1996; 11: 151-160.